1219633-05-2

Basic information

• Product Name: ethyl 5-phenyl-3,6-dihydro-2H-pyran-4-carboxylate
• Synonyms: ethyl 5-phenyl-3,6-dihydro-2H-pyran-4-carboxylate
• CAS NO: 1219633-05-2
• Molecular Weight: 232.279
• Mol File: 1219633-05-2.mol

Chemical Properties

• Boiling Point: 350℃
• Flash Point: 145℃
• Density: 1.132
• CAS DataBase Reference: ethyl 5-phenyl-3,6-dihydro-2H-pyran-4-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: ethyl 5-phenyl-3,6-dihydro-2H-pyran-4-carboxylate(1219633-05-2)
• EPA Substance Registry System: ethyl 5-phenyl-3,6-dihydro-2H-pyran-4-carboxylate(1219633-05-2)

Safety Data

• Hazardous Substances Data: 1219633-05-2(Hazardous Substances Data)

Upstream product

• 324767-92-2 ethyl 5-hydroxy-3,6-dihydro-2H-pyran-4-carboxylate 
• 388109-26-0 ethyl 3-oxotetrahydro-2H-pyran-4-carboxylate 
• 1068522-32-6 ethyl 5-(((trifluoromethyl)sulfonyl)oxy)-3,6-dihydro-2H-pyran-4-carboxylate 
• 98-80-6 phenylboronic acid 

Relevant articles and documents

HETEROCYCLIC COMPOUND

The present invention provide a heterocyclic compound having a HDAC inhibitory action, and useful for the treatment of autoimmune diseases and/or inflammatory diseases, graft versus host disease, cancers, central nervous diseases including neurodegenerative diseases, Charcot-Marie-Tooth disease and the like, and a pharmaceutical composition comprising the compound. The present invention relates to a compound represented by the formula (I): wherein each symbol is as defined in the specification, or a salt thereof.

BICYCLIC HETEROARYL COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN

Provide herein are compounds and pharmaceutical compositions suitable as modulators of hemoglobin, methods and intermediates for their preparation, and methods for their use in treating disorders mediated by hemoglobin and disorders that would benefit from tissue and/or cellular oxygenation.

Compounds and uses thereof for the modulation of hemoglobin

Provide herein are compounds and pharmaceutical compositions suitable as modulators of hemoglobin, methods and intermediates for their preparation, and methods for their use in treating disorders mediated by hemoglobin and disorders that would benefit from tissue and/or cellular oxygenation.

OXOPIPERIDINYL AND PYRANYL SULFONAMIDES AS AMPA POTENTIATORS

The invention is directed to a class of compounds, including the pharmaceutically acceptable salts of the compounds, having the structure of Formula (I) : as defined in the specification. The invention is also directed to compositions containing the compo